Limited Diagnostic Value of microRNAs for Detecting Colorectal Cancer: A Meta-analysis |
Zhou, Xuan-Jun
(Department of Clinical Laboratory, Qilu Hospital, Shandong University)
Dong, Zhao-Gang (Department of Clinical Laboratory, Qilu Hospital, Shandong University) Yang, Yong-Mei (Department of Clinical Laboratory, Qilu Hospital, Shandong University) Du, Lu-Tao (Department of Clinical Laboratory, Qilu Hospital, Shandong University) Zhang, Xin (Department of Clinical Laboratory, Qilu Hospital, Shandong University) Wang, Chuan-Xin (Department of Clinical Laboratory, Qilu Hospital, Shandong University) |
1 | Kalimutho M, Del Vecchio Blanco G, Di Cecilia S, et al (2011). Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer. J Gastroenterol, 46, 1391-402. DOI ScienceOn |
2 | Kanaan Z, Rai SN, Eichenberger MR, et al (2012). Plasma miR-21: a potential diagnostic marker of colorectal cancer. Ann Surg, 256, 544-51. DOI |
3 | Koga Y, Yasunaga M, Takahashi A, et al (2010). MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev Res (Phila), 3, 1435-42. DOI ScienceOn |
4 | Collins JF, Lieberman DA, Durbin TE, et al (2005). Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med, 142, 81-5. DOI ScienceOn |
5 | Corte H, Manceau G, Blons H, et al (2012). MicroRNA and colorectal cancer. Dig Liver Dis, 44, 195-200. DOI ScienceOn |
6 | Wang S, Wang L, Bayaxi N, et al (2013a). A microRNA panel to discriminate carcinomas from high-grade intraepithelial neoplasms in colonoscopy biopsy tissue. Gut, 62, 280-9. DOI ScienceOn |
7 | Wang S, Xiang J, Li Z, et al (2013b). A plasma microRNA panel for early detection of colorectal cancer. Int J Cancer. |
8 | Whiting P, Rutjes AW, Reitsma JB, et al (2003). The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol, 3, 25. DOI ScienceOn |
9 | Whiting P, Rutjes AW, Reitsma JB, et al (2004). Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med, 140, 189-202. DOI ScienceOn |
10 | Wu CW, Ng SS, Dong YJ, et al (2012). Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut, 61, 739-45. DOI ScienceOn |
11 | Zhang B, Pan X, Cobb GP, et al (2007). MicroRNAs as oncogenes and tumor suppressors. Dev Biol, 302, 1-12. DOI ScienceOn |
12 | Zhou T, Zhang G, Liu Z, et al (2013). Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Int J Colorectal Dis, 28, 19-24. DOI ScienceOn |
13 | Liu K, Li G, Fan C, et al (2011). Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer. J Int Med Res, 39, 2288-95. DOI |
14 | Mandel JS (2008). Screening for colorectal cancer. Gastroenterol Clin North Am, 37, 97-115, vii. DOI ScienceOn |
15 | Mitchell PS, Parkin RK, Kroh EM, et al (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A, 105, 10513-8. DOI ScienceOn |
16 | Reitsma JB, Glas AS, Rutjes AW, et al (2005). Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol, 58, 982-90. DOI ScienceOn |
17 | Ng EK, Chong WW, Jin H, et al (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 58, 1375-81. DOI ScienceOn |
18 | O’Connell JB, Maggard MA, Ko CY (2004). Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst, 96, 1420-5. DOI ScienceOn |
19 | Pu XX, Huang GL, Guo HQ, et al (2010). Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol, 25, 1674-80. DOI ScienceOn |
20 | Schetter AJ, Leung SY, Sohn JJ, et al (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-36. |
21 | Schetter AJ, Nguyen GH, Bowman ED, et al (2009). Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res, 15, 5878-87. DOI ScienceOn |
22 | Wang B, Zhang Q (2012). The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol, 138, 1659-66. DOI ScienceOn |
23 | Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, et al (2010). Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis. Ann Intern Med, 153, 368-77. DOI ScienceOn |
24 | Deville WL, Buntinx F, Bouter LM, et al (2002). Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol, 2, 9. DOI |
25 | Levin B, Lieberman DA, McFarland B, et al (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin, 58, 130-60. DOI ScienceOn |
26 | Wang Q, Huang Z, Ni S, et al (2012). Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One, 7, e44398. DOI |
27 | Deeks JJ, Macaskill P, Irwig L (2005). The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol, 58, 882-93. DOI ScienceOn |
28 | Gallagher EJ. (1998). Clinical utility of likelihood ratios. Ann Emerg Med, 31, 391-7. DOI ScienceOn |
29 | Giraldez MD, Lozano JJ, Ramirez G, et al (2013). Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin Gastroenterol Hepatol, 11, 681-8 e3. DOI ScienceOn |
30 | Glas AS, Lijmer JG, Prins MH, et al (2003). The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol, 56, 1129-35. DOI ScienceOn |
31 | Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. DOI ScienceOn |
32 | Huang Z, Huang D, Ni S, et al (2010). Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer, 127, 118-26. DOI ScienceOn |
33 | Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300. DOI |
![]() |